Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-gamma is elevated in patients with hepatitis C infection

被引:19
作者
Bansal, AS
Bruce, J
Hogan, PG
Prichard, P
Powell, EE
机构
[1] PRINCESS ALEXANDRA HOSP, LIONS HUMAN IMMUNOL LAB, BRISBANE, QLD 4102, AUSTRALIA
[2] PRINCESS ALEXANDRA HOSP, DEPT GASTROENTEROL & HEPATOL, BRISBANE, QLD 4102, AUSTRALIA
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1997年 / 84卷 / 02期
关键词
D O I
10.1006/clin.1997.4371
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The increased frequency of autoantibodies and B cell non-Hodgkins lymphoma (B-NHL) in hepatitis C virus (HCV) infection suggests dysregulated humoral immunity. Soluble CD23 (sCD23) is involved in B cell activation and proliferation and the serum levels are raised in autoimmune diseases and B cell lymphoproliferative disease. We compared the serum levels of sCD23 in patients with HCV infection with those in patients with alcoholic cirrhosis (AC) and in healthy controls. Serum levels of interleukin (IL) 8, IL10, granulocyte macrophage-colony stimulating factor, and interferon-gamma were assessed simultaneously to check for generalized nonspecific immune stimulation. In contrast to the essentially normal serum levels of these latter cytokines, the levels of sCD23 were raised in the patients with HCV compared to those with AC and the normal controls (medians 34.0, 10.1, and 11.1 arbitrary units, respectively; HCV vs AC P < 0.0004, HCV vs controls P < 0.0001, AC vs controls P > 0.8). These results confirm HCV-induced humoral immune dysregulation and invite comparison with primary Sjogrens syndrome and Epstein-Barr virus infection, both of which are also associated with raised levels of serum sCD23, autoantibodies, and B-NHL. (C) 1997 Academic Press.
引用
收藏
页码:139 / 144
页数:6
相关论文
共 36 条
[1]   SOLUBLE CD23 AND INTERLEUKIN-4 LEVELS IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALJANADI, M ;
ALWABEL, A ;
RAZIUDDIN, S .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 71 (01) :33-37
[2]   CROSS REACTION OF ANTIBODIES TO A GLYCINE ALANINE REPEAT SEQUENCE OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-1 WITH COLLAGEN, CYTOKERATIN, AND ACTIN [J].
BABOONIAN, C ;
VENABLES, PJW ;
WILLIAMS, DG ;
WILLIAMS, RO ;
MAINI, RN .
ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (11) :772-775
[3]  
BANSAL A, 1992, CLIN EXP IMMUNOL, V89, P452
[4]  
BANSAL AS, 1993, IMMUNOLOGY, V79, P285
[5]  
BANSAL AS, 1994, CLIN EXP RHEUMATOL, V12, P281
[6]  
BANSAL AS, 1994, CLIN EXP IMMUNOL, V97, P239
[7]  
BONNEFOY JY, 1993, EUR J IMMUNOL, V23, P969
[8]   LONGITUDINAL-STUDY OF ANTIBODIES AGAINST THYROID IN PATIENTS UNDERGOING INTERFERON-ALPHA THERAPY FOR HCV CHRONIC HEPATITIS [J].
CARELLA, C ;
AMATO, G ;
BIONDI, B ;
ROTONDI, M ;
MORISCO, F ;
TUCCILLO, C ;
CHIUCHIOLO, N ;
SIGNORIELLO, G ;
CAPORASO, N ;
LOMBARDI, G .
HORMONE RESEARCH, 1995, 44 (03) :110-114
[9]   HIGH PREVALENCE OF SEROLOGICAL MARKERS OF AUTOIMMUNITY IN PATIENTS WITH CHRONIC HEPATITIS-C [J].
CLIFFORD, BD ;
DONAHUE, D ;
SMITH, L ;
CABLE, E ;
LUTTIG, B ;
MANNS, M ;
BONKOVSKY, HL .
HEPATOLOGY, 1995, 21 (03) :613-619
[10]  
DELESPESSE G, 1991, ADV IMMUNOL, V49, P149